Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
RIDE ON EXPRESS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 38%, Oct-Dec Ordinary Profit Decreases by 26%
6082 RIDE ON EXPRESS HOLDINGS Co.,Ltd. 【J-GAAP】
Earnings ReportRIDE ON EXPRESS HOLDINGS Co.,Ltd. <6082> [TSE Std] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded 0.46 billion yen, an increase 37.9% compared to the same period last year. However, Progress toward the full-year plan of 1.25 billion yen was 37.1%, also falling below the five-year average of 64.1%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 2.1 times that of the same period last year, reaching 0.78 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit decreased to 0.27 billion yen, a 26.3% decrease compared to the same period last year. The operating profit margin worsened from 5.5% in the same period last year to 3.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 17,556 | 513 | 508 | 221 | 22.8 | 49.6 | Feb 14, 2024 | J-GAAP |
| Apr - Dec, 2024 | 17,147 | 350 | 338 | 156 | 16.0 | 46.9 | Feb 14, 2025 | J-GAAP |
| Apr - Dec, 2025 | 17,629 | 494 | 466 | 243 | 24.9 | 37.1 | Feb 13, 2026 | J-GAAP |
| YoY | +2.8% | +41.1% | +37.9% | +55.8% | +55.4% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 12,736 | 789 | 752 | 390 | 40.0 | 15 | May 15, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 12,448 | 578 | 1,061 | 642 | 65.5 | 15 | Dec 19, 2025 | J-GAAP |
| YoY | -2.3% | -26.7% | +41.1% | +64.6% | +63.8% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 23,995 | 1,067 | 1,024 | 364 | 37.4 | 15 | May 15, 2024 | J-GAAP |
| Mar, 2025 | 23,393 | 781 | 721 | 333 | 34.2 | 15 | May 15, 2025 | J-GAAP |
| Mar, 2026 Guidance | 23,377 | 810 | 1,255 | 724 | 73.9 | 15 | Dec 19, 2025 | J-GAAP |
| YoY | -0.1% | +3.7% | +74.1% | +117.4% | +116.4% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 6,490 | 358 | 369 | 213 | 21.9 | 5.5 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 6,246 | 431 | 383 | 177 | 18.2 | 6.9 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 5,225 | 50 | 51 | 20 | 2.1 | 1.0 | Aug 14, 2025 | J-GAAP |
| Jul - Sep, 2025 | 5,704 | 182 | 143 | 62 | 6.4 | 3.2 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 6,700 | 262 | 272 | 161 | 16.5 | 3.9 | Feb 13, 2026 | J-GAAP |
| YoY | +3.2% | -26.8% | -26.3% | -24.4% | -24.6% |
Related Articles
TAKARA BIO, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
Rigaku Holdings, 10% Increase in Net Income for The Current Fiscal Year, Dividend Raised by 0.2 Yen
APPLE INTERNATIONAL, 67% Increase in Ordinary Profit for The Current Fiscal Year
ANABUKI KOSAN, First Half Ordinary Profit Increases by 45%, Exceeds Full-Year Plan
TAKEDA iP, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 5%, Oct-Dec Ordinary Profit Decreases by 13%
Human Technologies, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 20%
KNC Laboratories, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 6%
Atlas Technologies, 2.9 times Increase in Ordinary Profit for The Current Fiscal Year
Cominix, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 30%, Oct-Dec Ordinary Profit Increases by 3.2 times
Human Holdings, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%, Oct-Dec Ordinary Profit Decreases by 17%